Competitive Advantages
- Lower toxicity to health tissues
- Greater targeting efficiency
- Enhanced diagnostic capability
Summary
A research team at the University of South Florida has developed a chitosan functionalized magnetic graphene nanoparticle (CMG) platform for simultaneous gene and/or drug delivery, and enhanced imaging of tumor cells. CMGs provide a robust and safe theranostic platform, which integrates targeted delivery of both gene therapies and chemotherapeutic drug(s), and enhanced imaging of tumors. This provides a treatment for cancers that will reduce the overall toxicity to healthy tissues, increase dosage efficiency, and provide for greater diagnostics of therapy and disease progressions.
Chitosan Functionalized Magnetic Graphene (CMG) Nanoparticles Provide a Robust and Safe Theranostic Platform Targeted to Tumors
Desired Partnerships
- License
- Sponsored Research
- Co-development